Authors:
COLEVAS AD
BUSSE PM
NORRIS CM
FRIED M
TISHLER RB
POULIN M
FABIAN RL
FITZGERALD TJ
DREYFUSS A
PETERS ES
ADAK S
COSTELLO R
BARTON JJ
POSNER MR
Citation: Ad. Colevas et al., INDUCTION CHEMOTHERAPY WITH DOCETAXEL, CISPLATIN, FLUOROURACIL, AND LEUCOVORIN FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE III TRIAL/, Journal of clinical oncology, 16(4), 1998, pp. 1331-1339
Authors:
SONIS ST
SINGER JW
BUSSE PM
MOSES GE
LUCEY CA
EDWARDS LJ
Citation: St. Sonis et al., EFFECTS OF LISOFYLLINE ON RADIOTHERAPY-INDUCED MUCOSAL TOXICITY IN HAMSTERS, Journal of dental research, 77, 1998, pp. 292-292
Authors:
SONIS S
HALEY JD
BUSSE PM
MOSES GE
LUCEY CA
EDWARDS LJ
Citation: S. Sonis et al., AN ANIMAL-MODEL FOR MUCOSITIS INDUCED BY FRACTIONATED RADIATION EXPOSURE, Journal of dental research, 77, 1998, pp. 2102-2102
Authors:
CLARK JR
BUSSE PM
NORRIS CM
ANDERSEN JW
DREYFUSS AI
ROSSI RM
POULIN MD
COLEVAS AD
TISHLER RB
COSTELLO R
LUCARINI JW
LUCARINI D
THORNHILL L
LACKEY M
PETERS E
POSNER MR
Citation: Jr. Clark et al., INDUCTION CHEMOTHERAPY WITH CISPLATIN, FLUOROURACIL, AND HIGH-DOSE LEUCOVORIN FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - LONG-TERM RESULTS, Journal of clinical oncology, 15(9), 1997, pp. 3100-3110
Authors:
WONG JS
RECHT A
BEARD CJ
BUSSE PM
CADY B
CHAFFEY JT
COME S
FAM S
KAELIN C
LINGOS TI
NIXON AJ
SHULMAN LN
TROYAN S
SILVER B
HARRIS JR
Citation: Js. Wong et al., TREATMENT OUTCOME AFTER TANGENTIAL RADIATION-THERAPY WITHOUT AXILLARYDISSECTION IN PATIENTS WITH EARLY-STAGE BREAST-CANCER AND CLINICALLY NEGATIVE AXILLARY NODES, International journal of radiation oncology, biology, physics, 39(4), 1997, pp. 915-920
Citation: Pm. Busse, RADIOTHERAPY FOR LARYNGEAL AND HYPOPHARYNGEAL CANCERS, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 130-130
Authors:
KIM HK
JESSUP JM
BEARD CJ
BORNSTEIN B
CADY B
STONE MD
BLEDAY R
BOTHE A
STEELE G
BUSSE PM
Citation: Hk. Kim et al., LOCALLY ADVANCED RECTAL-CARCINOMA - PELVIC CONTROL AND MORBIDITY FOLLOWING PREOPERATIVE RADIATION-THERAPY, RESECTION, AND INTRAOPERATIVE RADIATION-THERAPY, International journal of radiation oncology, biology, physics, 38(4), 1997, pp. 777-783
Authors:
DREYFUSS AI
CLERK JR
NORRIS CM
ROSSI RM
LUCARINI JW
BUSSE PM
POULIN MD
THORNHILL L
COSTELLO R
POSNER MR
Citation: Ai. Dreyfuss et al., DOCETAXEL - AN ACTIVE-DRUG FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Journal of clinical oncology, 14(5), 1996, pp. 1672-1678
Authors:
BUSWELL L
RECHT A
CLARK J
RAVIKUMAR T
BUSSE PM
COLEMAN CN
Citation: L. Buswell et al., COMBINED-MODALITY THERAPY OF ESOPHAGEAL CANCER WITH RADIOTHERAPY, ETANIDAZOLE, AND CISPLATIN-FLUOROURACIL, WITH OR WITHOUT SURGERY - NEUROTOXICITY, OTHER TOXICITIES AND OUTCOME, International journal of radiation oncology, biology, physics, 29(3), 1994, pp. 535-540
Citation: Cm. Norris et al., EVOLVING ROLE OF SURGERY AFTER INDUCTION CHEMOTHERAPY AND PRIMARY SITE RADIATION IN HEAD AND NECK-CANCER, Seminars in surgical oncology, 9(1), 1993, pp. 3-13
Authors:
BUSSE PM
JESSUP JM
CADY B
BOTHE A
MCDERMOTT WV
STONE MD
STEELE G
Citation: Pm. Busse et al., EFFECT OF COMBINED-MODALITY THERAPY ON THE SURGICAL-MANAGEMENT OF LOCALLY ADVANCED RECTAL-CARCINOMA, Seminars in surgical oncology, 9(1), 1993, pp. 46-50
Authors:
BUSSE PM
CLARK JR
BEARD CJ
DREYFUSS AI
LUCARINI JW
ROSSI R
CASEY D
NORRIS CM
Citation: Pm. Busse et al., PRIMARY SITE MANAGEMENT FOLLOWING INDUCTION CHEMOTHERAPY WITH CISPLATINUM, 5-FLUOROURACIL, AND LEUCOVORIN, Head & neck, 15(5), 1993, pp. 413-418